Results from Rhapsido (remibrutinib) pivotal Phase III RemIND trial, the largest study in chronic inducible urticaria, to be highlighted in late-breaker oral presentationNew Phase IIIb REMIXED extensi ...

Results from Rhapsido (remibrutinib) pivotal Phase III RemIND trial, the largest study in chronic inducible urticaria, to be ...

Chocolate lovers who suffer from nut allergies need to take note of a new recall, as ignoring it could harm your health — or worse. A report published on the National Institutes of Health website ...

Right now, there's no cure. But there are treatments.

Safety Monitoring Committee (SMC) recommended initiation of Part B of the peanut allergy trial Funding secured for follow-on tree (Fagales) pollen program MY010 Schlieren/Zurich, Switzerland, May 19, ...

Feeding toddlers tiny amounts of peanuts could treat their allergy within three years, a study suggests. Peanut allergy affects about one in 50 children in the UK, it is often lifelong and can lead to ...

Please provide your email address to receive an email when new articles are posted on . The LEAP Siblings study evaluated the younger siblings of LEAP trial participants. Early peanut introduction ...

DEAR DR. ROACH: I recently underwent skin scratch testing for food allergies. I was shocked that among the positive findings was peanuts. I have eaten peanuts all of my life (I’m 55) and have never ...

Dear Dr. Roach: I recently underwent skin scratch testing for food allergies. I was shocked that among the positive findings was peanuts. I have eaten peanuts all of my life (I'm 55) and have never ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A woman with a life-threatening peanut allergy has told Newsweek about ...

Peanut allergy affects approximately 2% of people in the U.S. and is the leading cause of fatal and near-fatal allergic reactions. Physicians are in short supply. They are costly. Is the APP the ...